Evidence map›Paper›PMID 33917377›Full record

ArticleJournal of personalized medicine2021

Evaluation of Social Cognition Measures for Japanese Patients with Schizophrenia Using an Expert Panel and Modified Delphi Method.

Hiroki Okano, Ryotaro Kubota, Ryo Okubo, Naoki Hashimoto, Satoru Ikezawa, Atsuhito Toyomaki, Akane Miyazaki, Yohei Sasaki, Yuji Yamada, Takahiro Nemoto and 1 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. International perspective on social cognition in schizophrenia: current stage and the next steps.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiroki OkanoDepartment of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.
Ryotaro KubotaDepartment of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.
Ryo OkuboDepartment of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.ORCID 0000-0002-1254-1926
Naoki HashimotoDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.ORCID 0000-0001-8311-7148
Satoru IkezawaEndowed Institute for Empowering Gifted Minds, University of Tokyo Graduate School of Arts and Sciences, Tokyo 153-0041, Japan.ORCID 0000-0003-4712-9373
Atsuhito ToyomakiDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.ORCID 0000-0001-9333-8833
Akane MiyazakiDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.ORCID 0000-0001-7903-6572
Yohei SasakiTranslational Medical Center, National Center of Neurology and Psychiatry, Department of Clinical Epidemiology, Tokyo 187-8551, Japan.
Yuji YamadaDepartment of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo 187-8551, Japan.ORCID 0000-0002-2169-1635
Takahiro NemotoDepartment of Neuropsychiatry, Toho University Faculty of Medicine, Tokyo 143-8541, Japan.
Masafumi MizunoDepartment of Neuropsychiatry, Toho University Faculty of Medicine, Tokyo 143-8541, Japan.

Funding

Japan Agency for Medical Research and Development JP20dk0307092
6 · The paper itself

Abstract

Social cognition is strongly linked to social functioning outcomes, making it a promising treatment target. Because social cognition measures tend to be sensitive to linguistic and cultural differences, existing measures should be evaluated based on their relevance for Japanese populations. We aimed to establish an expert consensus on the use of social cognition measures in Japanese populations to provide grounds for clinical use and future treatment development. We assembled a panel of experts in the fields of schizophrenia, social psychology, social neuroscience, and developmental disorders. The panel engaged in a modified Delphi process to (1) affirm expert consensus on the definition of social cognition and its constituent domains, (2) determine criteria to evaluate measures, and (3) identify measures appropriate for Japanese patients with a view toward future quantitative research. Through two online voting rounds and two online video conferences, the panel agreed upon a definition and four-domain framework for social cognition consistent with recent literature. Evaluation criteria for measures included feasibility and tolerability, reliability, clinical effectiveness, validity, and international comparability. The panel finally identified nine promising measures, including one task originally developed in Japan. In conclusion, we established an expert consensus on key discussion points in social cognition and arrived at an expert-selected set of measures. We hope that this work facilitates the use of these measures in Japanese clinical scenarios. We plan to further examine these measures in a psychometric evaluation study.

Indexed as

developmental disordersfacial expression recognitionmental disordersneeds surveyquality of lifeschizophreniasocial cognitionsocial functionsystematic reviewtest battery

Identifiers

PMID33917377
PMCPMC8067370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.